<DOC>
	<DOCNO>NCT01841970</DOCNO>
	<brief_summary>Hemorrhoids vascular cushion anal canal . People normally born hemorrhoid , presence hemorrhoid imply disease . However , hemorrhoid typically cause symptom enlarge time . There two type hemorrhoids- External Hemorrhoids Internal Hemorrhoids . Current minimally invasive technology treatment internal hemorrhoid associate several drawback include high rate recurrence need repetitive procedure , frequent post-procedural pain significant discomfort , intra-operative pain technically demand . The purpose study determine whether HET Bipolar System safe effective treatment Stage I Stage II hemorrhoid ( internal hemorrhoid ) . The HET Bipolar System new alternative device minimally invasive treatment Stage I Stage II hemorrhoid incorporate design feature intent resolve major limitation currently available technology .</brief_summary>
	<brief_title>Safety Efficacy Study HET Bipolar System Treatment Stage I Stage II Hemorrhoids</brief_title>
	<detailed_description>In study , investigator use HET Bipolar System treatment Stage I Stage II hemorrhoid , significant tissue prolapse present . The hemorrhoid treat bipolar ligation superior hemorrhoidal blood supply . Each prospective subject screen inclusion exclusion criterion least one week prior treatment . All patient undergo treatment review sign study Informed Consent prior procedure . One three internal hemorrhoid treat one therapeutic session . The number base investigator 's judgment quadrant symptomatic . Evaluations record treated subject immediately follow treatment . Subjects follow 1 , 3 , 6 month post procedure unless complication report scheduled follow-up date . At post treatment follow-up , report make pain/discomfort , bleeding , medication use , itching , presence adverse event complication need supplemental treatment . Face-to-face follow-up evaluation include anoscopic evaluation assessment hemorrhoid relevant symptom .</detailed_description>
	<mesh_term>Hemorrhoids</mesh_term>
	<criteria>Subject 21 year age General good health Subject undergo elective treatment Stage I Stage II internal hemorrhoid Chronic bleeding Stage I Stage II internal hemorrhoid ( least weekly occurrence Failure prior medical management Under 21 year age . Gastrointestinal bleed source internal hemorrhoid Active proctitis Inflammatory bowel disease HIV positive immunocompromised Rectal wall prolapse Stage III Stage IV hemorrhoids Medical condition require anticoagulant and/or subject receive anticoagulant within 7 day initial examination Pregnancy Rectal malignancy Hepatitis C Liver cirrhosis End stage renal disease Receiving chemotherapy Advanced malignancy Documented bleeding diathesis Treatment investigational drug medical device past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>